abiraterona 500 mg – inhibidor de la CYP17 en cáncer de próstata metastásico resistente a castración
Primary tabs
| Time | Referrer | User | Operations |
|---|---|---|---|
| 10/08/2025 - 17:28 | node/7427/track | Anonymous (not verified) | details |
| 10/08/2025 - 12:44 | node/7427/track | Anonymous (not verified) | details |
| 10/07/2025 - 12:36 | node/7427/track | Anonymous (not verified) | details |
| 10/07/2025 - 05:58 | http://www.longlive.com/question... | Anonymous (not verified) | details |
| 10/07/2025 - 02:12 | node/7427/track | Anonymous (not verified) | details |
| 10/06/2025 - 00:42 | node/7427/track | Anonymous (not verified) | details |
| 10/05/2025 - 21:27 | node/7427/track | Anonymous (not verified) | details |
| 10/05/2025 - 21:27 | node/7427/track | Anonymous (not verified) | details |
| 10/05/2025 - 21:26 | node/7427/track | Anonymous (not verified) | details |
| 10/05/2025 - 21:26 | node/7427/track | Anonymous (not verified) | details |